Dr Yvonne Selecki is the Clinical Trials Medical Officer in Garvan's Osteoporosis and Translational Research lab. Her presentation, "From Dubbo to Darlo", explains the research Garvan is doing through our Dubbo Osteoporosis Epidemiology Study (DOES).

DOES began in 1989 and is the longest running, large scale study of osteoporotic fractures in men and women.

As part of the study almost 4,000 blood samples have been taken from participants to provide a greater understanding of the factors that contribute to improvement or deterioration of bones, and the impact of those changes on quality of life and survival.

свернуть